Skip to main content
MedApt
  • Log in

Efsitora Matches Degludec for Efficacy and Safety in Diabetes

Submitted by centrix_admin on Wed, 09/17/2025 - 17:44
Tags
Long acting
  • Read more about Efsitora Matches Degludec for Efficacy and Safety in Diabetes

Bipolar Catheter Ablation Shows High Success for Intramural Ventricular Arrhythmias

Submitted by centrix_admin on Wed, 09/17/2025 - 17:33
  • Read more about Bipolar Catheter Ablation Shows High Success for Intramural Ventricular Arrhythmias

Early PVCs Double Risk of Recurrence After PAF Ablation

Submitted by centrix_admin on Wed, 09/17/2025 - 17:22
Tags
Atrial Fibrillation
  • Read more about Early PVCs Double Risk of Recurrence After PAF Ablation

Septal Purkinje Capture Explains Narrow QRS in Left Bundle Branch Area Pacing

Submitted by centrix_admin on Wed, 09/17/2025 - 17:02
  • Read more about Septal Purkinje Capture Explains Narrow QRS in Left Bundle Branch Area Pacing

Automated Insulin Delivery Improves Glycemic Control in Type 2 Diabetes Regardless of C-Peptide

Submitted by centrix_admin on Tue, 09/16/2025 - 17:44
Tags
Others Delivery devices
  • Read more about Automated Insulin Delivery Improves Glycemic Control in Type 2 Diabetes Regardless of C-Peptide

Not All TAVI Valves Are Equal: Self-Expanding Platforms Show Better Outcomes

Submitted by centrix_admin on Tue, 09/16/2025 - 17:28
  • Read more about Not All TAVI Valves Are Equal: Self-Expanding Platforms Show Better Outcomes

Meta-Analysis Confirms GLP-1 Therapy Improves Outcomes in Obese Patients With HFpEF

Submitted by centrix_admin on Tue, 09/16/2025 - 17:16
  • Read more about Meta-Analysis Confirms GLP-1 Therapy Improves Outcomes in Obese Patients With HFpEF

The Heart of The Matter: Unveiling the SOUL Study Results

Submitted by centrix_admin on Tue, 09/16/2025 - 17:04
Tags
GLP-1 agonists
  • Read more about The Heart of The Matter: Unveiling the SOUL Study Results

A Deep Dive into Trial Design & Patient Profiles

Submitted by centrix_admin on Tue, 09/16/2025 - 16:51
Tags
GLP-1 agonists
  • Read more about A Deep Dive into Trial Design & Patient Profiles

Higher-Dose Semaglutide (7.2 mg) Yields Drives Greater Weight and Glycemic Benefits in T2D

Submitted by centrix_admin on Tue, 09/16/2025 - 16:45
  • Read more about Higher-Dose Semaglutide (7.2 mg) Yields Drives Greater Weight and Glycemic Benefits in T2D

Pagination

  • Previous page ‹‹
  • Page 245
  • Next page ››
Subscribe to Health Business